Fecal Lactoferrin as a New Marker of Disease Activity in Inflammatory Bowel Diseases

Study of cut-off level for Fecal Calprotectin and Its Relation to Endoscopic and Histological Remission in IBD Egyptian Patients

Use of Fecal Calprotectin as A Predictor of Spontaneous Bacterial Peritonitis in Post Hepatitis C Cirrhotic Egyptian Patients

Comparative study the levels of plasma transforming growth factor-β1, serum crp, fecal lactoferrin, and fecal calprotectin as biomarkers for disease activity in Egyptian patients

Clostridium Difficile Infection (CDI) Among Egyptian Patients with Inflammatory Bowel Disease

Malnutrition among Patients with Inflammatory Bowel Disease in Specialized Center in Egypt

Evaluation of The Role of Fecal Microbiota Transplantation in The Management of Ulcerative Colitis in Egyptian Patients

A STUDY OF SOME BACTERIA OF THE GUT MICROBIOME IN EGYPTIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

FECAL CALPROTECTIN AND CRP AS BIOCHEMICAL MARKERS IN PREDICTING INFLAMMATORY BOWEL DISEASE ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS

Epidemiological and Clinical Characteristics of Inflammatory Bowel Disease in Egyptian Patients at the Nile Delta: A Single-Center Study